Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2013
10/23/2013CN103360366A Preparation methods of N-(2-methylpyridyl-5-nitro-3-)-4-(3-pyridinyl)pyrimidin-2-amine and intermediate thereof
10/23/2013CN103360312A Geldanamycin derivative and its application
10/23/2013CN103360310A Sitafloxacin intermediate, preparation method of sitafloxacin and sitafloxacin pharmaceutical composition
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102503935B Azelnidipine crystal form, preparation method for same and officinal composition thereof
10/23/2013CN102241667B 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
10/23/2013CN102036957B Compound comprising phenyl pyridine units
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/22/2013US8563746 Cyclic benzimidazole derivatives useful as anti-diabetic agents
10/22/2013US8563735 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/22/2013US8563734 2-[1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
10/22/2013US8563733 Process for the preparation of esomeprazole and salts thereof
10/22/2013US8563715 Pyrimidine derivative having cell protecting effect and uses thereof
10/22/2013US8563651 Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
10/22/2013US8563589 Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgamma
10/22/2013US8563576 Tri-cyclic pyrazolopyridine kinase inhibitors
10/22/2013US8563567 Substituted heterocyclic compounds
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563558 Substituted pyridine urea compounds
10/22/2013US8563556 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts
10/22/2013US8563526 Triazole derivatives, their preparation and their application in therapeutics
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2600507C 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
10/22/2013CA2587455C Substituted pyrazoles, compositions thereof, and their use as pesticides
10/22/2013CA2507807C Process for preparing optically pure proton pump inhibitors
10/17/2013WO2013155338A2 Substituted benzamides and their uses
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153780A1 Compound having acridan ring structure and organic electroluminescent element
10/17/2013WO2013153394A1 Quinolonones with antibacterial properties
10/17/2013WO2013152712A1 3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs
10/17/2013WO2013152392A1 Viral polymerase inhibitors
10/17/2013WO2013152391A1 Viral polymerase inhibitors
10/17/2013US20130274294 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
10/17/2013US20130274291 3'-deutero-pomalidomide
10/17/2013US20130274289 Methods of use of cyclic amide derivatives to treat schizophrenia
10/17/2013US20130274288 Biphenyl compounds useful as muscarinic receptor antagonists
10/17/2013US20130274275 4-phenylamino-quinazolin-6-yl-amides
10/17/2013US20130274272 Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
10/17/2013US20130274269 Novel substituted isoquinoline derivative
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274260 New compounds for the treatment of neurodegenerative diseases
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/17/2013US20130274243 Chemical Compounds
10/17/2013US20130274242 Substituted pyrimidine compounds and their use as syk inhibitors
10/17/2013US20130274241 Indazolyl triazol derivatives
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274218 Viral polymerase inhibitors
10/17/2013US20130274179 Viral polymerase inhibitors
10/17/2013US20130273581 Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
10/17/2013US20130273034 Novel compounds and compositions for the inhibition of nampt
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/17/2013US20130270524 Compound for organic light-emitting diode and organic light-emitting diode including the same
10/16/2013EP2650941A1 Organic electroluminescent element
10/16/2013EP2650290A1 Cyclic amine compound and pest control agent
10/16/2013EP2650286A1 Quinazoline derivatives and therapeutic use thereof
10/16/2013EP2650283A1 Process for producing substituted methylamine compound and triazine derivative
10/16/2013EP2650282A1 Process for producing substituted methylamine compound and triazine derivative
10/16/2013EP2649065A1 Bicyclic compounds as pim inhibitors
10/16/2013EP2649064A1 Novel triazole compounds iii
10/16/2013EP2649063A1 Triazole derivatives as wnt signaling pathway inhibitors
10/16/2013EP2649062A1 Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc)
10/16/2013EP2649061A1 Pyridine amide derivatives as ep4 receptor antagonists
10/16/2013EP2649060A2 Process for the preparation of benzimidazole derivatives and its salts
10/16/2013EP2649053A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/16/2013EP2649052A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
10/16/2013EP2649051A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
10/16/2013EP2649050A1 Compounds
10/16/2013EP2649048A1 Multifunctional nitroxide derivatives and uses thereof
10/16/2013EP2648731A1 Carboxamide compounds and their use as calpain inhibitors v
10/16/2013EP2648519A2 Novel polymorph of nilotinib hydrochloride
10/16/2013EP2648518A2 Pyrazole compounds for controlling invertebrate pests
10/16/2013EP2648511A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013EP2648510A1 Methods for the preparation of charged crosslinkers
10/16/2013CN103354811A Insecticidal compounds
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351388A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
10/16/2013CN103351381A Preparation method of imatinib and mesylate of imatinib
10/16/2013CN103351380A Preparation method of Bilastine
10/16/2013CN102702169B Method for preparing light stabilizer 3-dodecyl-1(1,2,2,6,6-pentamethyl piperidyl)-2,5-dipyrrolidone
10/16/2013CN102584789B Quinolinecarboxaldehyde schiff base, preparation method and application thereof
10/16/2013CN102417503B Preparation method of light stabilizer tris(2,2,6,6-tetramethyl-4-oxy-piperidyl)-1,3,5-triazine
10/16/2013CN102250022B Substituted quinoxalinamine compounds, and preparation method and application thereof
10/16/2013CN102126963B Spirobifluorene amido compound and preparation method thereof
10/16/2013CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents
10/16/2013CN102083799B Benzimidazole derivatives used as FXR agonists
10/16/2013CN102026997B Insecticidal compounds
10/16/2013CN101935301B Modulators of ATP-binding cassette transporters
10/16/2013CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis
10/16/2013CN101747320B Dialdehyde-built nitrogen or oxygen-containing heterocyclic compound with insect-killing activity and preparation method
10/16/2013CN101600706B Akt活性抑制剂 Akt activity inhibitor
10/16/2013CN101528733B 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CBL' receptor modulators
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557999 Pharmaceutical, dietary supplement, and food grade salts of anatabine
10/15/2013US8557997 Biphenyl compounds useful as muscarinic receptor antagonists
10/15/2013US8557849 Fungicide hydroximoyl-tetrazole derivatives
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 1080